• Home
• News
• About Us
• Contact

Search

Tag Cloud

anthrax Strategic National Stockpile Training exercise Bioterror Biomagnetics National Research Council Homeland Security Biodefense lab Army Medical Research Institute antibiotics Emergency preparedness research Bioweapons NIAID smallpox Detection technology CDC TSA Defense Dept IAEM FEMA immunization Ebola Ricin Hendra Plague treaty West Nile Camouflage Paint Marburg antidote weapons destruction Sarin VHF viruses chemical disposal dna technology prevention Robotics Technology research grants tularemia weapons control foot and mouth disease decontamination E. coli Iraq missile defense Bio-Rescue Dengue fever Botulinum toxin antiviral molecular diagnostics Infectious disease

Subscribe to our newsletter

RSS Feed

U.S. Army places order for biodetectors
by Tina Redlup on March 4, 2010

The U.S. Army has placed a purchase order with Universal Detection Technology for its 5-agent detection kits as well as for equipment for the detection of ricin and staphylococcal enterotoxin B.

California lab to be upgrade to respond to bioterrorism agents
by Daniel Purt on December 24, 2009

California's Stanislaus County has announced plans to upgrade its health lab to add sophisticated equipment that will be used to test for potential bioterrorism agents.

Warning issued to synthetic DNA manufacturers
by Paul Tinder on December 9, 2009

The Department of Health and Human Services has warned U.S. businesses trading in DNA to be on guard against abuses leading to bioterrorism.

Howard Goldstein joins Microchip Biotechnologies, Inc.
by Rita Uplend on December 2, 2009

Howard Goldstein has been named to the position of executive vice president of commercial affairs at Microchip Biotechnologies, Inc.

Guidelines proposed for businesses trading in custom-made DNA sequences
by Tina Redlup on December 1, 2009

A set of guidelines for how providers of custom-made DNA sequences do business has been proposed by the U.S. Department of Health and Human Services.

Gene synthesis firms unite to tighten security
by Pat Dulnier on November 23, 2009

The five companies - DNA 2.0, GeneArt, GenScript, Integrated DNA Technologies and Blue Heron Biotechnology - provide 80 percent of global gene synthesis capacity.